Companies

Blade Air Mobility Inc - Class A

NASDAQ: BLDE
$4.73
▲ $0.15 (+3.28%) today
Markets open · 4:15pm ET

About Blade Air Mobility

Strata Critical Medical, Inc. (Nasdaq: SRTA), formerly operating under the Blade brand, provides time-critical logistics and medical services to the U.S. healthcare industry. It operates an air transport and surgical services network for transplant hospitals and organ procurement organizations, offering an integrated 'one call' solution for donor organ recovery.

The company reports two segments:
- Logistics: air and ground transport of organs and medical teams, using owned and third-party aircraft.
- Clinical: split into Transplant Clinical (surgical organ recovery, organ placement and normothermic regional perfusion) and Other Clinical (perfusion staffing and equipment for cardiovascular surgery centers, plus a newly launched cardiothoracic surgical locum tenens line).

Strata sold its Passenger business to Joby Aviation in August 2025 and now reports continuing operations only. It is expanding its Clinical business through acquisitions, including Keystone (September 2025) and OVPA, LPS and HLT-NRP (Q2 2026), and is pursuing further M&A alongside a $20 million share repurchase program. Updated

BLDE Coverage

Frequently Asked Questions

What does Blade Air Mobility do?

Strata Critical Medical, Inc. (Nasdaq: SRTA), formerly operating under the Blade brand, provides time-critical logistics and medical services to the U.S. healthcare industry.